No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CTSO Cytosorbents
- 0.930
- +0.050+5.68%
Close May 6 16:00 ET
- 0.904
- -0.026-2.81%
Post 16:59 ET
50.50MMarket Cap-1453P/E (TTM)
0.973High0.870Low129.87KVolume0.919Open0.880Pre Close120.07KTurnover0.28%Turnover RatioLossP/E (Static)54.31MShares4.29052wk High2.17P/B43.78MFloat Cap0.78252wk Low--Dividend TTM47.07MShs Float98.750Historical High--Div YieldTTM11.67%Amplitude0.750Historical Low0.924Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
CytoSorbents Executives Take Pay Cuts for Stock Options
Cytosorbents Full Year 2023 Earnings: Misses Expectations
Cytosorbents Corporation (NASDAQ:CTSO) Q4 2023 Earnings Call Transcript
HC Wainwright & Co. Reiterates Neutral on CytoSorbents, Maintains $1 Price Target
HC Wainwright & Co. analyst Sean Lee reiterates CytoSorbents with a Neutral and maintains $1 price target.
Cytosorbents Financial and Clinical Study Outlook: Maintaining a Hold Rating
Earnings Call Summary | Cytosorbents(CTSO.US) Q4 2023 Earnings Conference
The following is a summary of the CytoSorbents Corporation (CTSO) Q4 2023 Earnings Call Transcript:Financial Performance:CytoSorbents Corporation reported a revenue of $36.3 million for the year, a 5%
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg